Erebagen develops software that uses bioinformatics to discover compounds for pharmaceuticals development.Erebagen2 FTE scientific post currently in the company.https://erebagen.com/2020PH Therapeutics is developing antibody therapies to treat Pulmonary Arterial Hypertension.PH TherapeuticsBackground IP related to a therapeutic targethttp://www.phtherapeutics.com2013Cambridge Photon Technology designs and manufactures its Photon Multiplier Film, which is nanotechnology that enables solar photovoltaic cells to capture energy more efficiently.Cambridge Photon TechnologyRSC Emerging Technologies Prize Deep Tech Pioneers Award- Hello Tomorrow Global Challenge Cambridge Photon Technology have been named one of six national finalists in the 2019 Shell Springboard competition.http://cambridgephoton.com2019Air Transportation Analytics provides data-driven analysis and consulting services to the air transport industry, covering economic, technological, and environmental factors.Air Transportation Analytics LimitedAlthough the models developed via the EPSRC grant have not yet been used in the company, we generated influential reports for the Department for Transport and the Committee on Climate Change.http://airtransportationanalytics.com2018Satsense develops software that uses satellite technology to measure subsidence rates.Satsensetbchttp://satsense.com2017IEEG LtdiEEG acquired venture capital from NorthStar Ventures in 2010 and licensed software developed to specifically facilitate infant EEG research derived from ES/I029907/1.2010HydRegen develops technology that enables companies to synthesise chemicals faster and at a lower cost.HydRegentoo early to statehttps://hydregenoxford.com/2020Panda Arts C.I.C.The company has been set up to carry our activities that will provide benefit to : * People who identify as neurodivergent and who wish to engage in the arts. * Children, young people and their families who have a diagnosis of autism and/ or identify as neurodivergent. * Children and young people who are awaiting or undergoing the process of diagnosis * Artists who identify as neurodivergent These activities are: * To produce 'in person' arts activities and events * To provide work opportunities and professional training for arts practitioners working within neurodiverse groups * To provide integrated work opportunities for artists who identify as neurodivergent * To be informed by, and contribute towards research in best practice in relation to Arts practices and neurodiversity with a strong focus on collaboration and participation * Produce on-line arts and training resources directed at families as well as arts workers, and provide an online platform for displaying arts content2023Polar OLED manufactures materials for use with printed OLED displays, wearables and lighting.Polar OLEDN/Ahttp://www.polaroled.com2008If Give develops an online platform which aims to help charities to run fundraising campaigns, and receive regular donations.If GiveThrough the establishment of IF GIVE LTD, the company has been invited to apply for seed funding via Innovate UK's ICure programme to support additional industrial research activities over a 12 month period. In particular, IF GIVE as a commercial entry has allowed the founding researchers to formalise and strengthen partnerships with NGOs including Oxfam Australia who are working closely with IF GIVE LTD to support design and productisation activities. As a company registered in the NW, we expect IF GIVE LTD to bring economic impacts to the region and will look to engage with smaller local charities and social good projects throughout.https://www.ifgive.app/2022Revolver Therapeutics researches and develops peptide-based inhibitors with the aim of producing treatments for cancers currently considered undruggable.Revolver TherapeuticsRevolver has only recenely spunout and is developing lead molecules and seeking fundraising.http://revolvertherapeutics.com2023Smartwound develops a wound dressing which can detect infections.SmartwoundNone yet...https://www.smartwound.co.uk/2021OBJECT Bio LtdObject Bio was incorporated in 2020 and it is therefore too early to describe any impacts.2020Innovative Solutions For Decision AgricultureThe project has combined historic data with remote sensing information and new field sampling techniques to create the first ever digital soil map of Africa. Built upon the principles of open innovation and co-development, the technologies and methodologies developed by AfSIS are freely available and remain highly relevant in other areas of the world.http://www.isda-africa.com2018Hyperspin Scientific LtdHyperSpin Scientific is a very small company, that has been established as a means to provide instrumentatino for hyperpolarization to the NMR community. So far, quotations have been issued to approximately half a dozen potential customers, and one customer has instructed his procurement team to raise a PO for a small amount (10 kEuro).http://www.hyperspin.biz2018Consequential Robotics develops assistive and companion robots that are designed to exhibit safe, human-centred behaviour. The robots have applications in social care with regards to improving the quality of life of elderly people.Consequential RoboticsConsequential Robotics is launching its first product in 2016, a biomimetic mammal-like robot.http://consequentialrobotics.com2014Graphia develops software that is capable of efficiently analysing and plotting large amounts of data from a variety of sources. The company claims that its software can be used by both experienced data analysts and non-specialist.GraphiaThe company is still at an early stage in its development but is beginning to gain commercial traction and clients for the software. We have won one Scottish Enterprise grant and have submitted a second for the development of our next generation software. We also secured seed investment of £230k last year. We are collaborating with academic scientists who develop network analysis algorithms or who use network analysis in their work. We have a number of ongoing discussions with major pharmaceutical and platform providers.http://kajeka.com2014T-Cypher Bio develops TCR (T-Cell Receptor) discovery software designed to identify TCRs for the treatment of tumours and other diseases.T-Cypher Biosuccessful fund raising, and recruitment of executive team and staffhttps://tcypherbio.com/2020Speak:Unique develops synthetic voices based on the person's voice that allows those losing their voice to use their own instead of a robotic sounding one.Speak:UniqueProduct release expected 2020http://speakunique.co.uk2018Puridify develops purification solutions for biotherapeutic manufacturing.PuridifyPuridify have proven at research scale (0.2mL reagent) that their technology can operate at 50x throughput due to better permeability and fast mass transfer. This improves process economics by increasing productivity and is also beneficial when processing labile products. The reagent has shown better resistance than our competitors to impurity fouling and cleaning steps, a common cause of performance degradation over multiple cycles. The technology allows cheap and rapid bioprocess development due to uniform performance at all scales, promoting its adoption in industry.http://www.puridify.com2013